Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kristian Reich

Showing results (71-80 of 265) with videos related to

Pageof 27
Sort By:
Journal of the American Academy of Dermatology|September 18, 2017
Efficacy and safety of ixekizumab for the treatment of moderate-to-severe plaque psoriasis: Results through 108 weeks of a randomized, controlled phase 3 clinical trial (UNCOVER-3)Andrew Blauvelt, Melinda Gooderham, Lars Iversen, et al.
Archives of Dermatological Research|February 2, 2008
Manifestation of palmoplantar pustulosis during or after infliximab therapy for plaque-type psoriasis: report on five casesRotraut Mössner, Diamant Thaci, Johannes Mohr, et al.
Archives of Dermatology|February 21, 2007
Clinical response of severe mechanobullous epidermolysis bullosa acquisita to combined treatment with immunoadsorption and rituximab (anti-CD20 monoclonal antibodies)Andrea Niedermeier, Rüdiger Eming, Martin Pfütze, et al.
Acta Dermato-Venereologica|October 12, 2018
Measuring Patient Needs and Benefits in Dermatology using the Patient Benefit Index 2.0: A Validation StudyJanine Topp, Matthias Augustin, Kathrin von Usslar, et al.
The Journal of Investigative Dermatology|September 17, 2002
Agonists of peroxisome proliferator-activated receptor gamma inhibit cell growth in malignant melanomaRotraut Mössner, Ulrike Schulz, Ullrich Krüger, et al.
The Journal of Allergy and Clinical Immunology|April 10, 2002
Evidence for a role of Langerhans cell-derived IL-16 in atopic dermatitisKristian Reich, Sabine Hugo, Peter Middel, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|July 22, 2014
Topical long-term therapy of psoriasis with vitamin D₃ analogues, corticosteroids and their two compound formulations: position paper on evidence and use in daily practiceMatthias Augustin, Ulrich Mrowietz, Bernd Bonnekoh, et al.
Contact Dermatitis|November 13, 2013
Glyceryl (mono)caprylate - a new contact allergenVerena G Herbert, Julia M Spiro, Kristian Reich, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 29, 2017
Matthias Augustin, Ulrich Mrowietz, Bernd Bonnekoh, et al.
Dermatology and Therapy|September 22, 2021
Short-Term Efficacy of Biologic Therapies in Moderate-to-Severe Plaque Psoriasis: A Systematic Literature Review and an Enhanced Multinomial Network Meta-AnalysisKyle Fahrbach, Grammati Sarri, David M Phillippo, et al.
Pageof 27

Showing results (71-80 of 265) with videos related to

Sort By:
Pageof 27
Journal of the American Academy of Dermatology|September 18, 2017
Efficacy and safety of ixekizumab for the treatment of moderate-to-severe plaque psoriasis: Results through 108 weeks of a randomized, controlled phase 3 clinical trial (UNCOVER-3)Andrew Blauvelt, Melinda Gooderham, Lars Iversen, et al.
Archives of Dermatological Research|February 2, 2008
Manifestation of palmoplantar pustulosis during or after infliximab therapy for plaque-type psoriasis: report on five casesRotraut Mössner, Diamant Thaci, Johannes Mohr, et al.
Archives of Dermatology|February 21, 2007
Clinical response of severe mechanobullous epidermolysis bullosa acquisita to combined treatment with immunoadsorption and rituximab (anti-CD20 monoclonal antibodies)Andrea Niedermeier, Rüdiger Eming, Martin Pfütze, et al.
Acta Dermato-Venereologica|October 12, 2018
Measuring Patient Needs and Benefits in Dermatology using the Patient Benefit Index 2.0: A Validation StudyJanine Topp, Matthias Augustin, Kathrin von Usslar, et al.
The Journal of Investigative Dermatology|September 17, 2002
Agonists of peroxisome proliferator-activated receptor gamma inhibit cell growth in malignant melanomaRotraut Mössner, Ulrike Schulz, Ullrich Krüger, et al.
The Journal of Allergy and Clinical Immunology|April 10, 2002
Evidence for a role of Langerhans cell-derived IL-16 in atopic dermatitisKristian Reich, Sabine Hugo, Peter Middel, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|July 22, 2014
Topical long-term therapy of psoriasis with vitamin D₃ analogues, corticosteroids and their two compound formulations: position paper on evidence and use in daily practiceMatthias Augustin, Ulrich Mrowietz, Bernd Bonnekoh, et al.
Contact Dermatitis|November 13, 2013
Glyceryl (mono)caprylate - a new contact allergenVerena G Herbert, Julia M Spiro, Kristian Reich, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 29, 2017
Matthias Augustin, Ulrich Mrowietz, Bernd Bonnekoh, et al.
Dermatology and Therapy|September 22, 2021
Short-Term Efficacy of Biologic Therapies in Moderate-to-Severe Plaque Psoriasis: A Systematic Literature Review and an Enhanced Multinomial Network Meta-AnalysisKyle Fahrbach, Grammati Sarri, David M Phillippo, et al.
Pageof 27